Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 3, 2008, Pages 247-253

  Iwai, Masae ^a   Takizawa, Takenori ^a   Nakayama, Takashi ^a   Matsuura, Kumiko ^a   Yoshida, Hiromu ^b   Hasegawa, Sumiyo ^a   Obara, Mayumi ^a   Horimoto, Eiji ^a   Kurata, Takeshi ^a   Horie, Hitoshi ^c  

^a TOYAMA INSTITUTE OF HEALTH   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c OHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE REGIMEN; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; POLIOMYELITIS VIRUS 2; POLIOMYELITIS VIRUS 3; RECOMMENDED DRUG DOSE; VACCINATION; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; JAPAN; NEUTRALIZATION TESTS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 39349095615     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701596003     Document Type: Article

References (25)

1. Takatsu, T., Tagaya, I. and Hirayama, M. (1973) Poliomyelitis in Japan during the period 1962-68 after the introduction of mass vaccination with Sabin vaccine. Bulletin WHO, 49, pp. 129-137.
2. Shimojo, H. (1984) Poliomyelitis control in Japan. Rev Infect Dis, 6, p. S427.
3. Infectious Agents Surveillance Center (1997) Poliomyelitis, Japan, 1962-1995. Infect Agents Surveillance Rep, 18, pp. 1-2.
4. Lago, PM, Bravo, JR, Andrus, JK, Comellas, MM, Galindo, MA and Quadros, CA (1994) Lessons from Cuba: Mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bulletin WHO, 72, pp. 221-225.
5. Ramsay, M., Begg, N., Gandhi, J. and Brown, D. (1994) Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. Pediatr Infect Dis J, 13, pp. 1117-1121.
6. World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines (1995) Factors affecting the immunogenicity of oral poliovirus vaccine: A prospective evaluation in Brazil and the Gambia. J Infect Dis, 171, pp. 1097-1106.
7. World Health Organization Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines (1997) Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman, and Thailand. J Infect Dis, 175, pp. 215-227.
8. Vaccine Administration Subcommittee (1966) Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children. Japan J Med Sci Biol, 19, pp. 277-291.
9. Vaccine Administration Subcommittee (1967) Evaluation of Sabin live poliovirus vaccine in Japan. III. Studies on the method of administration of Sabin vaccine for babies. Japan J Med Sci Biol, 20, pp. 151-166.
10. World Health Organization (2003) Global polio eradication initiative strategic plan 2004-2008. World Health Organization
11. Kew, OM, Wright, P., Agol, VI, Delpeyroux, F., Shimizu, H. and Nathanson, N. (2004) Circulating vaccine-derived polioviruses: Current state of knowledge. Bull WHO, 82, pp. 16-23.
12. Centers for Disease Control and Prevention (2006) Update on vaccine-derived polioviruses. MMWR, 55, pp. 1093-1097.
13. World Health Organization (2006) Weekly Epidemiological Record.81, pp. 61-68.
14. Matsuura, K., Ishikura, M., Yoshida, H., Nakayama, T., Hasegawa, S. and Ando, S. (2000) Assessment of poliovirus eradication in Japan: Genomic analysis of the polioviruses isolated from the river water and the sewage in Toyama Prefecture. Appl Environ Microbiol, 66, pp. 5087-5091.
15. Chumakov, KM, Powers, LB, Noonan, KE, Roninson, IB and Levenbook, IS. (1991) Correlation between amount of virus with acceptability of oral poliovirus vaccine. Proc Natl Acad Sci USA, 88, pp. 199-203.
16. Chumakov, KM, Dragunsky, EM, Norwood, LP, Douthitt, MP, Ran, Y. and Taffs, RE (1994) Consistent selection of mutations in the 5'-untranslated region of oral poliovirus vaccine upon passaging in vitro. J Med Virol, 42, pp. 79-85.
17. Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Ota, Y. and Nakayama, T. (2002) Neurovirulence of type 1 polioviruses isolated from sewage in Japan. Appl Environ Microbiol, 68, pp. 138-142.
18. Horie, H., Yoshida, H., Matsuura, K., Miyazawa, M., Wakabayashi, K. and Nomoto, A. (2002) Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan. J Med Virol, 68, pp. 445-451.
19. Yoshida, H., Horie, H., Matsuura, K., Kitamura, T., Hashizume, S. and Miyamura, T. (2002) Prevalence of vaccine-derived polioviruses in the environment. J Gen Virol, 83, pp. 1107-1111.
20. Yoshida, H., Horie, H., Matsuura, K. and Miyamura, T. (2000) Characterization of polioviruses isolated from sewage and river water in Japan. Lancet, 356, pp. 1461-1463.
21. Iwai, M., Nakayama, T., Matsuura, K., Hasegawa, S., Ando, S. and Obara, M. (2006) Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan. Acta Virologica, 50, pp. 139-143.
22. World Health Organization (1995) Manual of laboratory methods for potency testing of vaccines used in the WHO Expanded Programme on Immunization.
23. Shimizu, B. (2004) Poliovaccine. Rinsho to Biseibutsu, 31, pp. 349-353.
24. Modlin, FJ, Halsey, NA, Thomas, ML, Meschievitz, CK, Patriarca, PA and Baltimore Area Polio Vaccine Study Group (1997) Humoral and mucosal immunity in infants induced by 3 sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. J Infect Dis, 175, pp. 228-234.
25. Nishio, O., Ishihara, Y., Sakae, K., Nonomura, Y., Kuno, A. and Yasukawa, S. (1984) The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: Follow-up of vaccinees for 10 y. J Biol Stand, 12, pp. 1-10.